Trials / Completed
CompletedNCT04491214
Post ICU Follow up in Patients With Severe SARS-CoV-2 Infection (Covid-19)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 112 (actual)
- Sponsor
- University Hospital, Strasbourg, France · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Patients affected by new coronavirus infectious disease (COVID) were mostly hospitalized in ICU. This infection seems to cause widespread organ injury (i.e acute renal injury, neurological disorders, pulmonary embolism,…). It is therefore necessary to provide a framework for the follow up of patients. Moreover SARS-CoV-2 infection consequences remain unknow at this time. Study hypothesis is that COVID alters determining factors (physical or psychological) of quality of life after ICU hospitalisation. The aim of the study is to assess quality of life 3 months after ICU hospitalization. Secondary purposes of the study are 1) assessment of quality of life 6 months and the evolution between the third and the sixth months after ICU hospitalization 2) description patients care after 3 and 6 months ICU left and their clinical status 3) convening and providing a "platform" within several physicians (neurologist, biologist, pneumologist…) will be able to follow up patients and perform complementary investigations according to patients injuries.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | quality of live assessment | quality of live assessment 3 moth and 6 moth after ointensive care hospitalisation using SF36. |
Timeline
- Start date
- 2020-07-24
- Primary completion
- 2021-01-21
- Completion
- 2021-01-21
- First posted
- 2020-07-29
- Last updated
- 2021-02-12
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04491214. Inclusion in this directory is not an endorsement.